[ORGANIZATION]
National Health Commission of the People's Republic of China
Featured in 3 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
320 clusters · 1171 sources · last updated
Latest: GLP-1 weight-loss drugs may exacerbate eating disorders
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. However, safety concerns are
Also covered in
-
China expands family doctor contract services and referral systems
[HEALTH] · 3 sources ·